FDA Adverse Event Injury Summary report: N

WAVEWRITER ALPHA?

MDR report key: 22883493 · Received August 25, 2025

Report

Report Number
3006630150-2025-06847
Event Type
Injury
Date Received
August 25, 2025
Date of Event
July 19, 2025
Report Date
April 23, 2026
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
LGW
UDI-DI
08714729985099
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

B3: APPROXIMATED BASED ON THE DATE THE MANUFACTURER BECAME AWARE OF THE EVENT. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS. UPN: M365SC2352700. MODEL: SC-2352-70. SERIAL: (B)(6). BATCH: (B)(6). UDI: (B)(4). PRODUCT FAMILY: SCS-LINEAR LEADS. UPN: M365SC2352700. MODEL: SC-2352-70. SERIAL: (B)(6). BATCH: (B)(6). UDI: (B)(4).

Additional Manufacturer Narrative · 0

B3: ESTIMATED BASED ON GFE RESPONSE FROM SALES REPRESENTATIVE. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS, UPN: M365SC2352700, MODEL: SC-2352-70, SERIAL: (B)(6), BATCH: 7081620, UDI: (B)(4). PRODUCT FAMILY: SCS-LINEAR LEADS, UPN: M365SC2352700, MODEL: SC-2352-70, SERIAL: (B)(6), BATCH: 7081626, UDI: (B)(4).

Additional Manufacturer Narrative · 0

B3: ESTIMATED BASED ON GFE RESPONSE FROM SALES REPRESENTATIVE ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS UPN: M365SC2352700 MODEL: SC-2352-70 SERIAL: (B)(6). BATCH: 7081620 UDI: (B)(4). PRODUCT FAMILY: SCS-LINEAR LEADS UPN: M365SC2352700 MODEL: SC-2352-70 SERIAL: (B)(6) BATCH: 7081626 UDI: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THESE SPINAL CORD STIMULATION (SCS) DEVICES WERE EXPLANTED DUE TO AN UNKNOWN REASON. THE LOCATION OF THE DEVICES IS UNKNOWN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THESE SPINAL CORD STIMULATION (SCS) DEVICES WERE EXPLANTED DUE TO AN UNKNOWN REASON. THE LOCATION OF THE DEVICES IS UNKNOWN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT THIS SCS PATIENT UNDERWENT THE EXPLANT PROCEDURE DUE TO AN INFECTION THAT WAS INITIALLY LOCALIZED AT THE IMPLANTABLE PULSE GENERATOR (IPG) SITE, WHICH SUBSEQUENTLY PROGRESSED TO THE LEADS SITE AND EXTENDED TO THE CERVICAL SCAR. THE PRIMARY SYMPTOM WAS WOUND DRAINAGE ACCOMPANIED BY THE ONSET OF DEHISCING. THE PATIENT WAS SUBSEQUENTLY STARTED ON ANTIBIOTICS. THE PRECISE CAUSE OF THE INFECTION REMAINS UNDETERMINED; ALTHOUGH CULTURES WERE OBTAINED, THE RESULTS ARE NOT ACCESSIBLE. POSTOPERATIVELY, THE PATIENT WAS DOING WELL. THE DEVICES WERE RETAINED DUE TO HOSPITAL POLICY AND WILL NOT BE RETURNED FOR ANALYSIS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THESE SPINAL CORD STIMULATION (SCS) DEVICES WERE EXPLANTED DUE TO AN UNKNOWN REASON. THE LOCATION OF THE DEVICES IS UNKNOWN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT THIS SCS PATIENT UNDERWENT THE EXPLANT PROCEDURE DUE TO AN INFECTION THAT WAS INITIALLY LOCALIZED AT THE IMPLANTABLE PULSE GENERATOR (IPG) SITE, WHICH SUBSEQUENTLY PROGRESSED TO THE LEADS SITE AND EXTENDED TO THE CERVICAL SCAR. THE PRIMARY SYMPTOM WAS WOUND DRAINAGE ACCOMPANIED BY THE ONSET OF DEHISCING. THE PATIENT WAS SUBSEQUENTLY STARTED ON ANTIBIOTICS. THE PRECISE CAUSE OF THE INFECTION REMAINS UNDETERMINED; ALTHOUGH CULTURES WERE OBTAINED, THE RESULTS ARE NOT ACCESSIBLE. POSTOPERATIVELY, THE PATIENT WAS DOING WELL. THE DEVICES WERE RETAINED DUE TO HOSPITAL POLICY AND WILL NOT BE RETURNED FOR ANALYSIS. ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT THE IPG HAS BEEN RETURNED AND WILL UNDERGO ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
218448 WAVEWRITER ALPHA? STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION CORPORATION SC-1232 594167 08714729985099

Patients

Seq Age Sex Outcome Treatment
1